Gossamer Bio Inc (GOSS) — Strategic Asset Allocation Index
Gossamer Bio Inc (GOSS) has a Strategic Asset Allocation Index of 33.0% as of December 2022. Strategic assets (PP&E of $3.98 Million plus long-term investments of $-) total $3.98 Million, measured against net assets of $12.08 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check financial resilience of Gossamer Bio Inc to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Gossamer Bio Inc Strategic Asset Allocation Index (2019–2022)
This chart shows how Gossamer Bio Inc's Strategic Asset Allocation Index has evolved across 4 annual periods from 2019 to 2022. As of December 2022, the index stands at 33.0%, representing strategic assets of $3.98 Million against net assets of $12.08 Million USD. See financial flexibility index of Gossamer Bio Inc to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Gossamer Bio Inc (2019–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Gossamer Bio Inc from 2019 to 2022, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Gossamer Bio Inc market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.0% | $3.98 Million | $3.98 Million | $- | $12.08 Million | ▲ +28.6 pp |
| 2021 | 4.4% | $5.32 Million | $5.32 Million | $- | $121.46 Million | ▲ +2.7 pp |
| 2020 | 1.7% | $5.53 Million | $5.53 Million | $- | $320.68 Million | ▼ -2.7 pp |
| 2019 | 4.5% | $15.73 Million | $15.73 Million | $- | $352.49 Million | — |